Partnerships

Partnering and collaborations

IDP Pharma welcomes partnering opportunities to move forward its current programs and to explore the application of IDP Plarma’s technology to the discovery and development of first-in-class drugs modulating the activity of intrinsically disordered, disease driver transcription factors.

IDP Pharma has developed a whole new concept that allows to inhibit intrinsically disordered proteins in general, and disordered transcription factors in particular, by retaining proteins in a disorder, inactive state.

For partnering inquiries, please contact s (dot) esteban (at) idp (hyphen) pharma (dot) com.